DNA News and Research

RSS

DNA, or deoxyribonucleic acid, is the hereditary material in humans and almost all other organisms. Nearly every cell in a person’s body has the same DNA. Most DNA is located in the cell nucleus (where it is called nuclear DNA), but a small amount of DNA can also be found in the mitochondria (where it is called mitochondrial DNA or mtDNA).

Study sheds light on transport of enzyme involved in stem cell differentiation to DNA

Researchers at the Centre for Genomic Regulation in Barcelona, Spain, have identified the mechanism by which an important enzyme involved in the differentiation of stem cells is brought to the DNA.

3 Oct 2018

NIH Director's New Innovator Award for Vanderbilt professor

Reyna Gordon, PhD, assistant professor of Otolaryngology and director of the Music Cognition Lab in the Department of Otolaryngology at Vanderbilt University Medical Center, has received a National Institutes of Health (NIH) Director's New Innovator Award of $2.3 million in total costs for her project, "Biomarkers of Rhythmic Communication: Integrating Foundational and Translational Approaches."

3 Oct 2018

Immune protein 'flutters' like a butterfly in search of viruses, finds study

Researchers at Rutgers Robert Wood Johnson Medical School have identified an important step in the process that allows our bodies to fight viruses.

2 Oct 2018

Genetic variants reveal novel therapeutic targets for chronic kidney disease

The kidney does more than double or even triple duty compared to other organs - it extracts waste, balances body fluids, forms urine, regulates blood pressure, and secretes hormones.

1 Oct 2018

More people show interest in getting their DNA tested, finds new poll

Only a small percentage of people in their 50s and early 60s have had their DNA tested - either for medical reasons, to learn their ancestry or out of curiosity - but far more have an interest in getting such tests done, according to a new poll.

1 Oct 2018

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Seattle Genetics, Inc. and Takeda Pharmaceutical Company Limited announced today that the phase 3 ECHELON-2 clinical trial met its primary endpoint.

1 Oct 2018

TEAD1 protein appears to be important regulator of tumor migration in glioblastoma

A specific protein called TEAD1 is an important regulator of tumor migration in glioblastoma, the most common brain tumor in adults, and deactivating this protein may stop tumor cells from migrating away from the main tumor mass, according to research conducted at the Icahn School of Medicine at Mount Sinai and published October 1 in the journal Nature Communications.

1 Oct 2018

New analysis confirms value of minimal residual disease as prognostic indicator in multiple myeloma

Adaptive Biotechnologies today announced that Blood, the Journal of the American Society of Hematology, published online an analysis of patient samples from the Intergroupe Francophone du Myéloma 2009 trial.

1 Oct 2018

Xenex LightStrike Germ-Zapping Robots help reduce infection rates at Martin Medical Center

Patient safety is a top priority at Martin Medical Center, which recently announced that it has seen a significant reduction in its Clostridium difficile (C.diff) infection rates since adopting Xenex LightStrike Germ-Zapping Robots as its environmental standard of care.

1 Oct 2018

New project identifies immune checkpoint inhibition as potential treatment for angiosarcomas

Angiosarcoma Project, a patient-partnered genomics study, identified immune checkpoint inhibition as a potential treatment option for patients with angiosarcomas of the head, face, neck, or scalp, according to data presented at the fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference.

1 Oct 2018

FDA permits marketing of ClonoSEQ assay to detect minimal residual disease in blood cancer patients

Today the U.S. Food and Drug Administration permitted marketing of ClonoSEQ assay, a next generation sequencing-based test for minimal residual disease in patients with acute lymphoblastic leukemiaor multiple myeloma. MRD is a measure of the amount of cancer cells remaining in a person's bone marrow.

30 Sep 2018

Researchers deplete key protein for DNA replication using protein degradation system

Researchers from Tokyo Metropolitan University and the FIRC Institute of Molecular Oncology in Italy have succeeded in depleting AND-1, a key protein for DNA replication, by using a recently developed conditional protein degradation system.

29 Sep 2018

Australian scientists resolve a key question in ovarian cancer care

Australian scientists have revealed a better way to identify which patients should respond to powerful ovarian cancer drugs called PARP inhibitors (PARPi), resolving an important question in ovarian cancer care about why some patients respond to these drugs, while others do not.

28 Sep 2018

Research reveals how critical oocyte quality control process works

Females are born with a finite number of eggs that are steadily depleted throughout their lifetime. This reserve of eggs is selected from a much larger pool of millions of precursor cells, or oocytes, that form during fetal life.

28 Sep 2018

Synthetic DNA vaccine targets proteins overexpressed in several types of cancer

Scientists at The Wistar Institute have implemented a novel structurally designed synthetic DNA vaccine to simultaneously target multiple members of a family of proteins that are specifically overexpressed in several types of cancer.

28 Sep 2018

Food scientists can employ bacteriophage to destroy E. coli in drinking water

To rapidly detect the presence of E. coli in drinking water, Cornell University food scientists now can employ a bacteriophage - a genetically engineered virus - in a test used in hard-to-reach areas around the world.

28 Sep 2018

CNL, TRIUMF team up to enable revolutionary cancer treatment

TRIUMF, Canada's particle accelerator center, and Canadian Nuclear Laboratories, Canada's premier nuclear science and technology organization, are pleased to announce that they have agreed to pursue a strategic partnership around the commercial production of Actinium-225, a rare medical isotope that has the potential to serve as the basis of new ground-breaking cancer treatments.

28 Sep 2018

DNA News and Research

Further Reading

Study sheds light on transport of enzyme involved in stem cell differentiation to DNA

NIH Director's New Innovator Award for Vanderbilt professor

Immune protein 'flutters' like a butterfly in search of viruses, finds study

Genetic variants reveal novel therapeutic targets for chronic kidney disease

More people show interest in getting their DNA tested, finds new poll

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

TEAD1 protein appears to be important regulator of tumor migration in glioblastoma

New analysis confirms value of minimal residual disease as prognostic indicator in multiple myeloma

Xenex LightStrike Germ-Zapping Robots help reduce infection rates at Martin Medical Center

New project identifies immune checkpoint inhibition as potential treatment for angiosarcomas

FDA permits marketing of ClonoSEQ assay to detect minimal residual disease in blood cancer patients

Researchers deplete key protein for DNA replication using protein degradation system

Australian scientists resolve a key question in ovarian cancer care

Research reveals how critical oocyte quality control process works

Synthetic DNA vaccine targets proteins overexpressed in several types of cancer

Food scientists can employ bacteriophage to destroy E. coli in drinking water

CNL, TRIUMF team up to enable revolutionary cancer treatment

BHCGC consortium to play key role in NIH's large-scale effort to advance precision medicine

New discovery links proteins that control DNA packaging and cancer development

New approach promises to forecast cultivar resistance at much earlier stage

eBook: A guide to RNA sequencing eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest Life Science News